Struggling to spell r-e-l-i-e-f; though promising, sales of migraine drugs face hurdles

Article Abstract:

Migraine headaches are not sinus headaches and therefore, suffering for days, taking only over-the-counter pain relievers is not necessary. Glaxo Wellcome has two products, comprising about 86% of the market, that treat the special needs of the migraine sufferer. Zeneca Pharmaceuticals and Merck & Co. also have products. Pfizer will come out with one in 1999. The drug that works the fastest and most effectively on a migraine is called a triptan. Triptan sales grew 72% in 1996 but a large increase in sales is not expected in 1999.

Product information, Forecasts, trends, outlooks, Sales & consumption, Ethical Preparations, Care and treatment, Drugs, Migraine

---

Warner-Lambert to acquire Agouron Pharmaceuticals

Article Abstract:

Warner-Lambert Co. announced its purchase of Agouron Pharmaceuticals Inc. in a $2.1 billion stock deal. The New Jersey drug firm is looking to the future pipeline boost it can gain from the purchase of the little San Diego biotech firm. Agouron makes Viracept, the leading AIDS drug. Warner-Lambert makes Lipitor for cholesterol and Rezulin for diabetes.

Comment:

To be purchased by Warner-Lambert for $2.1 billion in stock

Asset sales & divestitures, Acquisitions & mergers, Antiinfective Preparations NEC, Pharmaceutical industry, Mergers, acquisitions and divestments, Anti-infective agents, Antineoplastic agents, Warner-Lambert Co., WLA, Agouron Pharmaceuticals Inc., AGPH

---

Similar abstracts:

• Abstracts: 4 drug makers move to settle in pricing suit. Old drugs, new labels. American Home Products buying Monsanto for $34.4 billion
• Abstracts: PennCorp seeks to score by reversing field. AIG ad starring heap of tires draws suit
• Abstracts: General Nutrition sets accord to open vitamin shops in Rite Aid drugstores
• Abstracts: Labels suggesting the benefits of drinking wine look likely. Appeals panel backs Gallo on Chardonnay packaging
• Abstracts: A Microsoft rebuttal but nothing to rebut. Apple executive testifies of threats and bullying by Microsoft

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.